agilon health, inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the agilon health, inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, agilon health, inc. has logged 204 reports. Market capitalisation: €1.6bn. The latest transaction was disclosed on 18 August 2026 (Retenue fiscale). Among the most active insiders: Shaker Benjamin. All data is free.
Analyst consensus: bullish or bearish? Analysts rate agilon health, inc. Hold (neutral), based on 13 analysts. Average price target: US$110.92.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,464 of 29,062 companies
FCF yld -10%
Earn yld -27%
EV/EBITDA ·
ROE -79%
Gross mgn -2.7%
Net mgn -6.6%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
All Executives204 Thresholds0 Prospectus0 Other0
Declarations 204 total
● Chief Accounting Officer · Executives · 16 Aug 2026
17 shares @ US$96.90 Common Stock SEC:0001628280-26-057781:0
● Chief Legal Officer · Executives · 1 Aug 2026
37 shares @ US$91.61 0.0002% mcap 14.1% of flow Common Stock SEC:0001628280-26-052624:0
◆ Director · Executives · 2 Jun 2026
2,133 shares 0Common Stock SEC:0001628280-26-041020:0
● Chief Accounting Officer · Executives · 24 May 2026
8 shares @ US$86.39 0.0002% mcap 0.4% of flow Common Stock SEC:0001628280-26-038601:0
● Chief Markets Officer · Executives · 15 Apr 2026
571 shares @ US$26.88 0.0008% mcap 0.3% of flow Common Stock SEC:0001628280-26-025587:1
● Chief Technology Officer · Executives · 15 Apr 2026
330 shares @ US$26.88 0.0005% mcap 22.5% of flow Common Stock SEC:0001628280-26-025589:1
● Chief Accounting Officer · Executives · 14 Apr 2026
25 shares @ US$22.68 0.0000% mcap 0.3% of flow Common Stock SEC:0001628280-26-025588:0
● Chief Accounting Officer · Executives · 15 Apr 2026
122 shares @ US$26.88 0.0002% mcap 1.8% of flow Common Stock SEC:0001628280-26-025588:1
● Chief Markets Officer · Executives · 14 Apr 2026
104 shares @ US$22.68 0.0001% mcap 0.0% of flow Common Stock SEC:0001628280-26-025587:0
● Chief Technology Officer · Executives · 14 Apr 2026
96 shares @ US$22.68 0.0001% mcap 5.5% of flow Common Stock SEC:0001628280-26-025589:0
● Chief Legal Officer · Executives · 14 Apr 2026
20 shares @ US$22.68 0.0000% mcap 4.8% of flow Common Stock SEC:0001628280-26-025590:0
● Chief Legal Officer · Executives · 15 Apr 2026
220 shares @ US$26.88 0.0003% mcap 63.0% of flow Common Stock SEC:0001628280-26-025590:1
◆ Chief Accounting Officer · Executives · 1 Apr 2026
10,000 shares 0Common Stock SEC:0001628280-26-023766:1
◆ Chief Financial Officer · Executives · 1 Apr 2026
75,000 shares 0Common Stock SEC:0001628280-26-023770:1
◆ Chief Markets Officer · Executives · 1 Apr 2026
70,000 shares 0Common Stock SEC:0001628280-26-023768:1
◆ Chief Technology Officer · Executives · 1 Apr 2026
28,000 shares 0Common Stock SEC:0001628280-26-023764:1
◆ Chief Legal Officer · Executives · 1 Apr 2026
50,000 shares 0Common Stock SEC:0001628280-26-023762:1
● Chief Accounting Officer · Executives · 1 Apr 2026
266 shares @ US$9.75 1.4% of flow Common Stock SEC:0001628280-26-023766:0
● Chief Financial Officer · Executives · 1 Apr 2026
1,662 shares @ US$9.75 2.9% of flow Common Stock SEC:0001628280-26-023770:0
● Chief Markets Officer · Executives · 1 Apr 2026
1,664 shares @ US$9.75 0.3% of flow Common Stock SEC:0001628280-26-023768:0
● Chief Technology Officer · Executives · 1 Apr 2026
480 shares @ US$9.75 10.8% of flow Common Stock SEC:0001628280-26-023764:0
● Chief Legal Officer · Executives · 1 Apr 2026
1,024 shares @ US$9.75 52.0% of flow Common Stock SEC:0001628280-26-023762:0
▲ Chief Legal Officer · Executives · 9 Mar 2026
5,535 shares Common Stock SEC:0001628280-26-016883:0
Canonical exit: 7 Jun 2026 (T+90) ▲ Chief Technology Officer · Executives · 9 Mar 2026
18,448 shares Common Stock SEC:0001628280-26-016882:0
Canonical exit: 7 Jun 2026 (T+90) ▲ Chief Markets Officer · Executives · 9 Mar 2026
18,448 shares Common Stock SEC:0001628280-26-016881:0
Canonical exit: 7 Jun 2026 (T+90) 25 of 204 declarations
Load more (179 remaining) 关于 agilon health, inc. agilon health, inc. 是一家总部位于美国的医疗保健公司,在纽约证券交易所上市,股票代码为 AGL。该公司成立于 2016 年,总部位于俄亥俄州 Westerville。其核心战略围绕着通过使独立的初级保健医生和医生团体以价值导向的护理模式而非按服务收费的结构运营,从而改变老年人的初级保健。通过其专门构建的平台和合作伙伴关系,agilon 提供资金、数据、支付方关系、运营支持和合同专业知识,使医生能够专注于其 Medicare 年龄患者的长期健康。该公司将其模式描述为“全面护理模式”,旨在保持医生独立性,同时为当地诊所提供管理老年人全风险或按人头付费安排的工具。
从商业模式的角度来看,agilon health 位于美国医疗保健市场一个专业且竞争激烈的领域。它不是传统的保险公司,也不是纯粹的医生执业管理整合者;相反,它是一个以规模化初级保健为重点的价值导向赋能平台。其经济表现取决于赢得和留住医生合作伙伴、保持与 Medicare Advantage 支付方的良好关系以及有纪律地管理医疗成本趋势。该公司的业务足迹具有全国性抱负,但在运营上,它通过选定的地理区域和当地市场合作伙伴关系进行扩张,而不是在全国范围内全面覆盖。管理层继续将机会框定在美国庞大且渗透不足的老年护理市场。
最近的发展表明 agilon 正处于一个要求严格的转型阶段。在其 2025 财年业绩中,该公司报告收入为 5.93 billion 美元,同比下降 2%,平台上的总会员数为 625,000 人,全年净亏损 391 million 美元。2025 年医疗利润转为负值,反映了医疗成本趋势上升和市场退出带来的影响。与此同时,管理层表示已完成旨在改善运营纪律、降低下行风险敞口并调整业务规模以实现更具弹性的 2026 年的行动。在其 2026 年 2 月的展望中,agilon 预计 2026 年调整后的 EBITDA 大致在盈亏平衡点附近,这表明其重点在于执行而非激进增长。
对于投资者而言,关键的解读是 agilon health 仍然是一个转型故事。该公司在一个结构上具有吸引力的细分市场中运营,该市场与老年护理、Medicare Advantage 渗透率以及向价值导向报销的转变相关。然而,投资案例对临床成本趋势、支付方合同经济学、医生合作伙伴保留以及公司将规模转化为可持续利润的能力高度敏感。简而言之,agilon 提供了一个引人注目的战略主题,但仍需要证明其持久的财务稳定性和持续的执行力。